IFF Claimed Company
Meet IFF:
We boldly bring together science and creativity to create what the world needs.
An industry leader in food, beverage, health and biosciences, we create essential solutions – from global icons to unexpected innovations and experiences. Equal parts outspoken and analytical, our international collective of thinkers working with customers to bring scents, tastes, experiences, ingredients and solutions for products people crave.
With 24,000 employees across 65 countries, more than 110 manufacturing facilities, 100 R&D centers, and 33,000 customers across the world, we’re poised to make a difference on an unprecedented scale. Without our boundary-pushing passion and end-to-end expertise, the future wouldn’t be the same.
Visit us at www.iff.com to learn more about how our talented people and new technology are challenging the expected, championing creators and doing more good for people and planet.
Explore what sets us apart. read more
Frank Clyburn — CEO at IFF
Executive Bio
Frank Clyburn has served as IFF’s Chief Executive Officer since February 2022.
Previously, he held the role of Executive Vice President and President of Human Health for Merck & Co. (Merck), where he had full P&L responsibility of their largest business. During his tenure, he was also responsible for building one of the leading oncology businesses in the world, which is the largest business within Merck and has transformed cancer care on a global scale.
Mr. Clyburn joined Merck in 2008 and held several positions including Chief Commercial Officer, the inaugural president of the company’s Global Oncology business, and President of its Primary Care and Women’s Health businesses. In addition to leading the creation of the Global Oncology business, Mr. Clyburn also executed the worldwide launch of Merck’s immuno-oncology medicine which helped establish the company as a leader in oncology.
Before joining Merck, Mr. Clyburn was Vice President of the Oncology and Internal Medicine business units at Sanofi Aventis and held a wide range of leadership roles with the company. In addition, was actively involved in the $65 billion integration of Sanofi and Aventis.
Mr. Clyburn received his Master of Business Administration degree from Arizona State University and his Bachelor of Arts degree from Franklin & Marshall College. Notably, he served on the Board of Directors of DuPont from June 1, 2019 to January 20, 2022. He currently serves on the Board of Directors for the European Feder
Previously, he held the role of Executive Vice President and President of Human Health for Merck & Co. (Merck), where he had full P&L responsibility of their largest business. During his tenure, he was also responsible for building one of the leading oncology businesses in the world, which is the largest business within Merck and has transformed cancer care on a global scale.
Mr. Clyburn joined Merck in 2008 and held several positions including Chief Commercial Officer, the inaugural president of the company’s Global Oncology business, and President of its Primary Care and Women’s Health businesses. In addition to leading the creation of the Global Oncology business, Mr. Clyburn also executed the worldwide launch of Merck’s immuno-oncology medicine which helped establish the company as a leader in oncology.
Before joining Merck, Mr. Clyburn was Vice President of the Oncology and Internal Medicine business units at Sanofi Aventis and held a wide range of leadership roles with the company. In addition, was actively involved in the $65 billion integration of Sanofi and Aventis.
Mr. Clyburn received his Master of Business Administration degree from Arizona State University and his Bachelor of Arts degree from Franklin & Marshall College. Notably, he served on the Board of Directors of DuPont from June 1, 2019 to January 20, 2022. He currently serves on the Board of Directors for the European Feder
Executive Team Culture Ratings from IFF Employees
TOP
5%
IFF's Executive Team scores in the Top 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
IFF's Executive Team at a Glance
Based on 133 ratings, IFF's employees are very satisfied with their Executive Team and give them an “A+” or 84/100. On average, Men provided higher ratings for their Executive Team compared to Women. Also, the Business Development department thinks more highly of the Executive Team relative to the Admin department.
IFF's Executive Team ranks in the Top 5% of other companies in New York and Top 5% of other companies on Comparably that also have 1,001-5,000 Employees.
×